(Q41156076)

27 September 2017

Heparin enhances angiogenesis by a systemic mode of action (English)

1 reference

27 September 2017

1 reference

Norrby K

1

1 reference

27 September 2017

Sörbo J

series ordinal

2

1 reference

27 September 2017

language of work or name

1 reference

1 April 1992

1 reference

International Journal of Experimental Pathology

27 September 2017

1 reference

27 September 2017

73

1 reference

27 September 2017

2

1 reference

27 September 2017

147-155

1 reference

Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001995

Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001995

Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001995

Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001995

Protamine and mast-cell-mediated angiogenesis in the rat.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001995

Do ischemic hearts stimulate endothelial cell growth?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001995

Heparin degradation in the endothelial cells

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001995

Specific binding of basic fibroblast growth factor to basement membrane-like structures and to purified heparan sulfate proteoglycan of the EHS tumor.

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001995

Improvement of treadmill capacity and collateral circulation as a result of exercise with heparin pretreatment in patients with effort angina.

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001995

Control of angiogenesis with synthetic heparin substitutes

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001995

Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001995

Inhibition of intimal hyperplasia after arterial injury by heparins and heparinoid

19 August 2018

1 reference

12 December 2020

Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells

1 reference

12 December 2020

Age-dependent mast-cell-mediated angiogenesis

1 reference

12 December 2020

Heparin-derived oligosaccharides: affinity for acidic fibroblast growth factor and effect on its growth-promoting activity for human endothelial cells

1 reference

12 December 2020

Angiogenesis factor from human myocardial infarcts

1 reference

12 December 2020

Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies

1 reference

12 December 2020

Identifiers

1 reference

27 September 2017

1 reference